Patronus Biotech Receives Ethical Approval to Begin First-in-Human Phase 1 Trial of Three Multi-Stage Vaccines Against Malaria in Australia
Bellberry Limited Research Ethics Committee approves first-in-human study in Australia of Patronus Biotech's novel multi-stage virus-like-particle (VLP)-based malaria vaccine candidates targeting Plasmodium falciparum and Plasmodium vivax GUANGZHOU, China, Oct. 20, 2026 /PRNewswire/ -- Patronus Biotech, a biotechnology company that develops next-generation vaccines to address unmet global needs, today announced that its Phase I first-in-human clinical trial NCT07831226 of...
Planet Green Holdings Corp. Provides Response to Unusual Market Action
NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Planet Green Holdings Corp. ("Planet Green", the "Company") (NYSE American: PLAG) announced today that the Company had become aware of unusual trading activity in its common stock on the New York Stock Exchange American (the "NYSE") on October 19, 2026. The Company is issuing this press release pursuant to Section 401(d)...
NeuroXT Inc. Receives U.S. FDA 510(k) Clearance for NEXT-Cue, AI Software Supporting Prognostic Assessment in Mild Cognitive Impairment
Supports clinicians in assessing progression from mild cognitive impairment to Alzheimer's dementia within five years NeuroXT Inc. to advance U.S. commercialization and adoption by healthcare institutions following FDA 510(k) clearance SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ -- NeuroXT Inc., a medical device manufacturer, announced that NEXT-Cue, its AI-based Software...
CAS collaborates with Microsoft to enable faster innovation in pharmaceutical, life sciences, and chemical industries
CAS ConnectionsSM integrates trusted human-curated scientific knowledge into Microsoft Copilot COLUMBUS, Ohio, Oct. 20, 2026 /PRNewswire/ -- CAS, a division of the American Chemical Society, today announced the availability of CAS Connections in Microsoft Copilot. The connector gives Copilot customers access to the CAS Content Collection™ and CAS NewtonSM, agentic AI...
Hospital Authority appreciates generous donation from Sino Group and Ng Teng Fong Charitable Foundation
HONG KONG, Oct. 20, 2026 /PRNewswire/ -- The Hospital Authority (HA) today (October 20) extends its heartfelt gratitude to Sino Group and Ng Teng Fong Charitable Foundation for their generous donation of a combined total of $30 million to support the establishment of two operating theatres dedicated to cataract surgery. The theatres are expected to come into service in...
Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion
Founder Tim Johnson to become Executive Chairman, continuing to drive long-term strategy, technology innovation and product development Leadership evolution designed to accelerate commercial execution, pursue strategic acquisitions and enhance long-term shareholder value Experienced leadership to drive scalable growth: Sanjay Shrestha, former President of Plug Power, brings public-company leadership, capital markets...
QVAXB40 Initiative Expands Access to PeKa Sihat Health Screening Across Malaysia
Collaboration pledges up to 100,000 free influenza vaccines as an entry point to preventive health screening for underserved B40 communities. PETALING JAYA, Malaysia, Oct. 20, 2026 /PRNewswire/ -- Qualitas Medical Group Sdn. Bhd. ("Qualitas") and ProtectHealth Corporation Sdn. Bhd. ("ProtectHealth") are collaborating through the QVAXB40 initiative to encourage more eligible Malaysians to undergo health screening under the recently...
Xinhua Silk Road: Bailong Chuangyuan to showcase star products at SupplySide Global 2026 in Las Vegas
BEIJING, Oct. 20, 2026 /PRNewswire/ -- At the SupplySide Global to be held during October 28-30 in Las Vegas, U.S., Chinese functional ingredient producer Shandong Bailong Chuangyuan Bio-tech Co., Ltd. will exhibit and present a series of its star and innovative products. The company, an industry pacesetter headquartered in Shandong Province, east China, currently produces more than 200 types...
New Innovative Molecular Technology Combination “LAMP + CRISPR” as CE-IVD
A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAMP and CRISPR. By integrating these two methods, eazySNP enables the rapid and highly specific detection...
Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication
Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 20, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced China's National Medical Products Administration ("NMPA") had formally accepted the registration application for Profhilo's facial indication in September. This milestone...
